Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glutathione sodium is the sodium salt form of reduced glutathione (GSH), an endogenous tripeptide antioxidant composed of the amino acids glycine, cysteine, and glutamic acid. It functions as a major thiol-disulfide redox buffer in cells and serves as a powerful antioxidant capable of scavenging oxygen-derived free radicals. Glutathione participates in leukotriene synthesis, acts as a cofactor for glutathione peroxidase, and plays a crucial role in the hepatic biotransformation and detoxification processes. It's involved in the detoxification of methylglyoxal (a toxic byproduct of metabolism) through glyoxalase enzymes and can participate in both enzymatic and non-enzymatic conjugation with certain chemicals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glutathione sodium.